RST-Sanexas
Advanced Quantum-based Technology for Pain Management, Circulation, and Rehabilitation

Resonant Specific Technologies, Inc. and Sanexas Corporation owned and operated by Lisa Sorgnard located in Las Vegas, NV has been in business since 2001. Better known in the medical industry as RST-Sanexas the company name is derived from the Latin meaning of SANUS – “Health or Healing” + NEXUS – “Network or Connection” SANUS + NEXUS = “A Healthy Network or Healing Connection” that stimulate the body to heal itself through electric cell-signaling treatments (EcST).

Quantum Physics Approach

The energy approach to healing has been around and used in medicine dating back centuries. It has been only in the past 15 years that the value of this method of treatment has become more accepted and is now being taught at many leading medical schools. Studies have shown that how cells function with the use of electrical current involve basic rules of physics and chemistry.

RST-Sanexas neoGEN®-Series

Introducing the RST-Sanexas neoGEN®-Series—a well-established and exciting quantum-based medical electric cell-signaling technology (EcST). The system goes far beyond traditional TENS and NMES therapy because the ultra-high digital frequency generator (UHdfg) delivers targeted and combined FM and AM electronic energy signals that penetrate much deeper into the tissue. These therapeutic energy waves produce complex electric cell-signaling processes along with associated harmonic resonance frequencies which will imitate, facilitate, exhaust, or interrupt the neuron’s axonal action potential. The ever-changing signals make it almost impossible for the peripheral and central nervous system to find ways to accommodate or ignore. The program’s parameters provide excellent pain management, circulation improvements and better rehabilitation outcomes in a safe, effective, non-invasive, and non-pharmaceutical way. RST-Sanexas neoGEN®-Series device produces vibratory oscillations at the cellular level to help reduce inflammation, edema, and stimulate nerves to re-grow by activating the regenerative repair processes.

Neurons have a membrane potential difference in the electric charge between the inside and outside of the cell. This membrane potential is expressed as a negative potential because the inside of the cell is negatively charged compare to the outside. Application of specific parameter electrical stimulus make the membrane potential more positive.

This effect and increase in distribution mediated by electric cell-signaling technology (EcST) results in

1. Dilution of toxic, pain and/or inflammation producing substances.

2. Increase of filtration and diffusion processes (tissue clearance).

We provide complete integrative healthcare solutions and support diagnoses and therapy in hospitals, clinics, and private practice facilities with our innovative medical systems

3. Increase in local blood flow.

4. Improvement of exchange processes of intracellular and extracellular fluids.

5. Enhanced water electro-osmosis within the tissue.

6. Improvement of the resorption processes that are important for treating inflammatory and edematous conditions.

Treating the Pain of Peripheral Neuropathy

Neuropathy is a condition in which the peripheral nerves (the nerves in the body, aside from the spinal cord and brain) are damaged and/or not working correctly. Neuropathic pain is characterized by sharp pain and numbness in the feet and lower legs, balance and coordination problems, muscle weakness, and tingling and burning sensations. The estimated prevalence of peripheral neuropathy among adults with diabetes in the US is 28 percent and eventually affects nearly 50 percent of adults with diabetes during their lifetime. With diabetes being the leading cause, there can be many other healthcare issues including trauma (partially or completely severing a peripheral nerve), some chemotherapy drugs, amputation, alcohol, heavy metals, toxic chemical exposure i.e., Agent Orange, and idiopathic that affect the patient’s outcome. The neoGEN® treatment system can be effectively used for the management of pain caused by peripheral neuropathy. It enhances the regenerative processes within cells through the following methods:



• Increasing cellular proton motive force and electron transfer across the cell membrane via increased polarity via microtubule conduction

• Inductive recharging cell membrane potential (capacitance)

• Increased cellular polarity, which leads to improved cellular energy storage in the cytoskeleton (ATP)

• Improved cellular communication (via gap junction response)

• Improved tissue/organ function

Besides neuropathy pain, RST-Sanexas neoGEN® device helps other conditions

• Increases and improves circulation

• Helps reduce inflammation and edema

• Neuromuscular re-education

• Reduces post-surgical/ post traumatic pain (acute)

• Provides muscle relaxation

• Improves functional outcome and the immune system via gap-function response

• Prevents and retards tissue atrophy

• Relieves chronic long-term, intractable pain

Treatment is Safe, Non-Invasive, Effective, and Non-Pharmaceutical

Depending on proper diagnosis, the neoGEN®-Series electric cell-signaling treatments (EcST) can begin. Depending on the diagnosis, it normally takes approximately 10-15 varied-parameter treatments with the individual treatment time ranging from 10-30 minutes per session 2-3 times per week over a time. Depending on the patient’s physiology and the lack of reparative energy in their bodies, treatment is cumulative and may not be noticeable until weeks later. The length of sessions will depend on the patient’s re-evaluation and their verbal feedback reporting pain relief, improved sleep, increased activity and better balance, less need for pain medication, etc. There are times when the patient may feel like the pain got worse, but this is normal because nerves are sprouting new growth. Regenerating new nerves, growing new nerve axons, and exciting existing damaged nerves will take time.A patient who developed chemotherapy-induced peripheral neuropathy (CIPN) was referred by her Board- Certified Medical Oncologist to undergo electric cell- signaling treatment using the RST-Sanexas neoGEN® device because her neuropathy symptoms were severe to the extent she wanted to discontinue her chemotherapy treatment. As a result of her (EcST) neoGEN® treatment, she was able to successfully complete her chemotherapy regimen.

Mission Statement

Our partnership affiliations with scientific research and technical development have driven the growth of our company by numerous product innovations for the medical industry. Sanexas technology is based upon a history of complex engineering and electronics. We provide complete integrative healthcare solutions and support diagnoses and therapy in hospitals, clinics, and private practice facilities with our innovative medical systems.

We envision future directions of research and clinical use to include the synergistic and cost saving incorporation of electric cell-signaling technology with recent developments in quantum physics. These developments pertain to biologic oscillation, neural networks, and microtubule functions in energy transfer, proton motive force, and cellular capacitance.

Published Clinical Research

The RST-Sanexas neoGEN-Series® system has numerous published medical journal reports and studies involving the successful treatment of multiple medical indications, syndromes, and neurogenic pain conditions. Copies of published research are available upon written request.